AgriTalk took an in-depth look at the issue of what happens when patents expire for biotech products last week and the interview is now available to listen to online.
The pharmaceutical industry has rules in place to manage drugs when their patents' expire and they become generic. But this is a whole new world for agricultural biotech traits. How do seed companies gain access to these traits for their customers? How does the industry maintain overseas approvals? Who's responsible for re-registration in the United States. These are issues the ag industry has to face soon when patents expire on such products as the Roundup Ready trait in soybeans.